PathoAnalyzer-I: An Integrative Bioinformatics Platform for Chronic Disease Analysis
Bioinformatics and Biology Insights · 2026-05 · 20
DOI: 10.1177/11779322261433663 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformatics and Biology Insights, online erschienen am 08.05.2026. Verfasst von Ali Aguerd und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Integrative Biology, Faculty of Science Ain Chock, University Hassan II, Casablanca, Morocco. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Chronic diseases impose a global health burden, contributing to high mortality and economic costs. Even with the recent surge in molecular data, these conditions remain largely incurable due to their biological complexity, data fragmentation, and analysis challenges, hindering early diagnosis, mechanistic understanding, and therapy. To address this, we developed PathoAnalyzer-I, an in silico platform that combines bioinformatics and machine learning to decipher chronic diseases. The tool requires no programming skills and provides a user-friendly interface for pathological analysis within a single framework. PathoAnalyzer-I uses a dataset of molecular data for 531 chronic diseases, from databases including the GWAS Catalog, PubChem, and STRING-db, enriched with machine learning–based predictions. Its dual-prediction system enhances molecular insights: one model imputes missing risk alleles with 77.6% accuracy, while a second predicts novel SNP–disease associations with 89.3% accuracy, providing avenues for future research. Applied to Alzheimer’s disease, the platform identified diagnostic biomarkers (e.g. rs6733839T), core genes in disease mechanisms (e.g. BIN1 , APOE , SLC24A4 , ABCA7 , PTK2B ), major pathological mechanisms like amyloid processing, synaptic dysfunction, and cellular vulnerability, as well as therapeutic molecules including Beta-Lapachone and preventive compounds such as curcumin. With its features, PathoAnalyzer-I enables scientists, regardless of their resources, to conduct in-depth in silico studies of chronic diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Integrative Biology, Faculty of Science Ain Chock, University Hassan II, Casablanca, Morocco.
ORCID-Profile: Ali Aguerd
Zitieren
APA
Aguerd, A., Bennis, F., & Chegdani, F. (2026). PathoAnalyzer-I: An Integrative Bioinformatics Platform for Chronic Disease Analysis. Bioinformatics and Biology Insights, 20. https://doi.org/10.1177/11779322261433663
Vancouver
Aguerd A, Bennis F, Chegdani F. PathoAnalyzer-I: An Integrative Bioinformatics Platform for Chronic Disease Analysis. Bioinformatics and Biology Insights. 2026;20. doi:10.1177/11779322261433663
BibTeX
@article{Aguerd2026,
author = {Aguerd, Ali and Bennis, Faiza and Chegdani, Fatima},
title = {PathoAnalyzer-I: An Integrative Bioinformatics Platform for Chronic Disease Analysis},
journal = {Bioinformatics and Biology Insights},
year = {2026},
volume = {20},
doi = {10.1177/11779322261433663}
}
EUVIMED